(19)
(11) EP 4 426 358 A2

(12)

(88) Date of publication A3:
22.06.2023

(43) Date of publication:
11.09.2024 Bulletin 2024/37

(21) Application number: 22814000.0

(22) Date of filing: 07.11.2022
(51) International Patent Classification (IPC): 
A61K 47/60(2017.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/60
(86) International application number:
PCT/EP2022/080986
(87) International publication number:
WO 2023/079142 (11.05.2023 Gazette 2023/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.11.2021 EP 21206761

(71) Applicant: TargImmune Therapeutics AG
4057 Basel (CH)

(72) Inventors:
  • KITAS, Eric
    4147 Aesch (CH)
  • ZIGLER, Maya
    4052 Basel (CH)
  • POMBO-VILLAR, Esteban
    4102 Binningen (CH)

(74) Representative: Latscha Schöllhorn Partner AG 
Grellingerstrasse 60
4052 Basel
4052 Basel (CH)

   


(54) TARGETED LINEAR CONJUGATES COMPRISING POLYETHYLENEIMINE AND POLYETHYLENE GLYCOL AND POLYPLEXES COMPRISING THE SAME